Abstract
Background: Prostate cancer-associated mortality is increasing at an alarming rate, which highlights the inevitability for unearthing novel agent for the management of this disease. Anethole, a major constituent of Foeniculum vulgare (fennel) essential oil, is widely used in folk medicine; it possesses anti-oxidant, antiinflammatory, anti-proliferative and tumoricidal potentialities.
Objective: The current research was conducted to assess the impact of anethole on prostate cancer cell line, PC- 3, and to delineate the molecular mechanism of action.
Methods: To achieve this aim, the growth-inhibitory effect of anethole was evaluated by MTT assay. Apoptotic death and cell cycle analyses were assessed by flow cytometry and alterations in gene expression were investigated by qPCR and Western blot analyses.
Results: The observations indicated that anethole inhibited proliferation, clonal growth and migration of PC-3 cells. It also suppressed growth of PC-3 derived cancer stem cells (tumorspheres). Pro-apoptotic potential of anethole was accompanied by generation of ROS, permeabilization of the mitochondrial and lysosomal membranes, activation of caspase-3 and -9, DNA damage, PARP cleavage and induction of Bax/Bcl-2 protein ratio. Further, anethole induced G2/M phase arrest, downregulation of cyclins D1, CDK-4 and c-Myc proteins and upregulation of p21 and p27. Anethole suppressed nuclear localization of NF-κB protein and downregulated transcription of NF-κB-dependent genes.
Conclusion: Overall, the above findings highlight the effectiveness of anethole as a potential candidate for prostate cancer therapy.
Keywords: Prostate cancer, apoptosis, oxidative stress, DNA damage, cell cycle, anethole.
Graphical Abstract
Anti-Cancer Agents in Medicinal Chemistry
Title:Anethole Inhibits the Proliferation of Human Prostate Cancer Cells via Induction of Cell Cycle Arrest and Apoptosis
Volume: 18 Issue: 2
Author(s): Ayman I. Elkady*
Affiliation:
- Zoology Department, Faculty of Science, Alexandria University, Alexandria,Egypt
Keywords: Prostate cancer, apoptosis, oxidative stress, DNA damage, cell cycle, anethole.
Abstract: Background: Prostate cancer-associated mortality is increasing at an alarming rate, which highlights the inevitability for unearthing novel agent for the management of this disease. Anethole, a major constituent of Foeniculum vulgare (fennel) essential oil, is widely used in folk medicine; it possesses anti-oxidant, antiinflammatory, anti-proliferative and tumoricidal potentialities.
Objective: The current research was conducted to assess the impact of anethole on prostate cancer cell line, PC- 3, and to delineate the molecular mechanism of action.
Methods: To achieve this aim, the growth-inhibitory effect of anethole was evaluated by MTT assay. Apoptotic death and cell cycle analyses were assessed by flow cytometry and alterations in gene expression were investigated by qPCR and Western blot analyses.
Results: The observations indicated that anethole inhibited proliferation, clonal growth and migration of PC-3 cells. It also suppressed growth of PC-3 derived cancer stem cells (tumorspheres). Pro-apoptotic potential of anethole was accompanied by generation of ROS, permeabilization of the mitochondrial and lysosomal membranes, activation of caspase-3 and -9, DNA damage, PARP cleavage and induction of Bax/Bcl-2 protein ratio. Further, anethole induced G2/M phase arrest, downregulation of cyclins D1, CDK-4 and c-Myc proteins and upregulation of p21 and p27. Anethole suppressed nuclear localization of NF-κB protein and downregulated transcription of NF-κB-dependent genes.
Conclusion: Overall, the above findings highlight the effectiveness of anethole as a potential candidate for prostate cancer therapy.
Export Options
About this article
Cite this article as:
Elkady I. Ayman *, Anethole Inhibits the Proliferation of Human Prostate Cancer Cells via Induction of Cell Cycle Arrest and Apoptosis, Anti-Cancer Agents in Medicinal Chemistry 2018; 18 (2) . https://dx.doi.org/10.2174/1871520617666170725165717
DOI https://dx.doi.org/10.2174/1871520617666170725165717 |
Print ISSN 1871-5206 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5992 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Reproductive Toxicology of Environmental Toxicants: Emerging Issues and Concerns
Current Pharmaceutical Design Signaling Processes in Tumoral Neuroendocrine Pituitary Cells as Potential Targets for Therapeutic Drugs
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Recent Advances and Strategies in Tumor Vasculature Targeted Nano-Drug Delivery Systems
Current Pharmaceutical Design Meet the Editorial Board Member
Current Drug Targets Is Src a Viable Target for Treating Solid Tumours?
Current Cancer Drug Targets Correlation between Potassium Channel Expression and Sensitivity to Drug-induced Cell Death in Tumor Cell Lines
Current Pharmaceutical Design Steroid Hormone Binding Receptors: Application of Homology Modeling, Induced Fit Docking, and Molecular Dynamics to Study Structure- Function Relationships
Current Topics in Medicinal Chemistry Vitamin D and Vitamin D Receptor Activators in Treatment of Hypertension and Cardiovascular Disease
Cardiovascular & Hematological Disorders-Drug Targets Exploring siRNA Umpired Nanogels: A Tale of Barrier Combating Carrier
Current Pharmaceutical Design Estrogen, Neuroprotection and Neurogenesis after Ischemic Stroke
Current Drug Targets Nanoscale Formulations and Diagnostics With Their Recent Trends: A Major Focus of Future Nanotechnology
Current Pharmaceutical Design Electronic Noses in Medical Diagnostics
Current Medicinal Chemistry Microbubble-Assisted p53, RB, and p130 Gene Transfer in Combination with Radiation Therapy in Prostate Cancer
Current Gene Therapy Small-Animal Molecular Imaging for Preclinical Cancer Research: μPET and μSPECT
Current Radiopharmaceuticals An Overview on Different Classes of Viral Entry and Respiratory Syncitial Virus (RSV) Fusion Inhibitors
Current Medicinal Chemistry Novel Superactive Leptin Antagonists and their Potential Therapeutic Applications
Current Pharmaceutical Design Targeting Heat Shock Proteins in Prostate Cancer
Current Medicinal Chemistry The Innate Immunity in Alzheimer Disease- Relevance to Pathogenesis and Therapy
Current Pharmaceutical Design Proteomics Approach to Illustrate Drug Action Mechanisms
Current Drug Discovery Technologies Microtubules in Apoptosis Induction: Are They Necessary?
Current Cancer Drug Targets